0.00Open0.05Pre Close0 Volume469 Open Interest55.00Strike Price0.00Turnover718.75%IV43.59%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0217Delta0.0079Gamma766.78Leverage Ratio-0.7456Theta0.0000Rho16.62Eff Leverage0.0005Vega
Rexford Industrial Realty Inc Stock Discussion
$Saia (SAIA.US)$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone (AZO.US)$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle (ORCL.US)$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings (BILL.US)$ was downg...
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...
• $Array Technologies (ARRY.US)$ +12.87% (also names new CEO)
• $Tufin Software Technologies (TUFN.US)$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals (CTXR.US)$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics (BTAI.US)$ +19.22% (FDA ha...
No comment yet